Systems Biology
Blood clot formation begins when blood vessels are damaged, exposing two proteins found in the vessel lining, tissue factor and collagen. When platelets come into contact with exposed collagen at the site of injury, they adhere to the wall of the broken vessel and secrete chemicals attracting other platelets, eventually forming a platelet plug. The plug is strengthened by a clotting factor called fibrin, which is produced through a sequence of reactions known as the coagulation cascade. This cascade involves proteins called coagulation factors, and the two primary factors of interest are thrombin and fibrinogen (which is converted to fibrin). Thrombin is produced when its inactive form called prothrombin is enzymatically cleaved, and it then converts fibrinogen into its active form, fibrin.
While blood clots are vital in stopping blood loss short-term, they need to be broken down to restore normal blood flow. This process is called fibrinolysis and is accomplished by an enzyme called plasmin.
Lesson Outline
<ul> <li>Blood clot formation begins when blood vessels are damaged</li> <ul> <li>Damage exposes tissue factor and collagen in the vessel lining, triggering clot formation</li> </ul> <li>Platelets in the bloodstream</li> <ul> <li>Adhere to exposed collagen at the site of injury</li> <li>Aggregate and secrete chemicals to attract more platelets</li> <li>Form a platelet plug to prevent blood loss and block intruders</li></ul> <li>Coagulation cascade</li> <ul> <li>Triggered by blood vessel damage</li> <li>Involves numerous coagulation factors</li> <li>Two key factors: thrombin and fibrinogen (which is converted to fibrin)</li> </ul> <li>Thrombin</li> <ul> <li>Produced by enzymatically cleaving prothrombin</li> <li>Converts fibrinogen into fibrin</li> </ul> <li>Fibrin</li> <ul> <li>Strengthens the platelet plug</li> <li>Not found freely in the blood</li> </ul> <li>Blood clot breakdown (fibrinolysis)</li> <ul> <li>Restores normal blood flow</li> <li>Accomplished by an enzyme called plasmin</li> </ul> </ul>
Don't stop here!
Get access to 71 more Systems Biology lessons & 8 more full MCAT courses with one subscription!
FAQs
Clot formation, also known as hemostasis, is a multi-step process that occurs when there is blood vessel damage. It involves the activation of platelets, the development of a platelet plug, and the activation of the coagulation cascade. Platelet plugs form when platelets in the blood become activated due to vessel damage and clump together to form a temporary barrier to seal the damaged area. This helps minimize blood loss and sets the stage for coagulation, with the ultimate goal of forming a stable blood clot.
The coagulation cascade is a complex series of enzymatic reactions involving coagulation factors, which ultimately leads to the formation of a blood clot. This cascade has both intrinsic and extrinsic pathways that converge in a common pathway, resulting in the conversion of prothrombin to thrombin. Thrombin, a key enzyme in this process, promotes the conversion of fibrinogen to fibrin, which further assembles into a mesh-like structure that stabilizes the blood clot, preventing further bleeding from the damaged vessel.
Fibrin is a key protein involved in the clotting process and plays a crucial role in stabilizing blood clots. Upon the activation of thrombin, fibrinogen is converted into fibrin monomers, which spontaneously assemble into fibrin fibers. This fibrin network forms a mesh-like structure that entraps platelets, red blood cells, and other components, creating a stable clot that adheres to the damaged blood vessel wall. Simultaneously, thrombin also activates Factor XIII, which cross-links the fibrin fibers, further strengthening the clot and maintaining its stability to effectively prevent further bleeding.
Fibrinolysis is the physiological process of breaking down blood clots, essential for maintaining a balance between clot formation and dissolution. Plasmin, a key enzyme in fibrinolysis, is responsible for degrading fibrin within the clot structure. It is initially produced as an inactive precursor, plasminogen, which is activated to plasmin by tissue plasminogen activator (tPA) or urokinase. Plasmin cleaves the fibrin mesh, generating soluble degradation products and ultimately leading to the dissolution of the clot. This controlled breakdown ensures proper wound healing, restoration of blood flow, and prevention of excessive clot formation.
MCAT® is a registered trademark of the Association of American Medical Colleges. The United States Medical Licensing Examination (USMLE®) is a joint program of the Federation of State Medical Boards (FSMB®) and National Board of Medical Examiners (NBME®). NAPLEX® is a registered trademark of the National Association of Boards of Pharmacy. PANCE© is a registered trademark of the National Commission on Certification of Physician Assistants. NCLEX® is a registered trademark and service mark of the National Council of State Boards of Nursing, Inc. None of the trademark holders are endorsed by nor affiliated with Sketchy or this website.
